ZFP810 inhibitors represent a class of compounds that specifically target the zinc finger protein 810 (ZFP810), a transcription factor involved in gene regulation. ZFP810 is characterized by its zinc finger motifs, which are structural domains that facilitate binding to specific DNA sequences, thereby influencing the transcription of downstream genes. Zinc finger proteins are one of the largest families of transcription factors in eukaryotic organisms, playing crucial roles in a wide range of cellular processes. The inhibition of ZFP810 interferes with its ability to bind to DNA and modulate gene expression, leading to downstream effects that alter cellular functions. These inhibitors are designed to interact with specific structural features of the protein, disrupting the function of its zinc finger domains. This inhibition can affect various gene expression pathways, depending on the specific targets regulated by ZFP810.
The development and study of ZFP810 inhibitors require a deep understanding of protein-DNA interactions, as well as the structural dynamics of zinc finger motifs. Such research involves detailed investigations into the molecular architecture of ZFP810, including crystallographic studies to reveal the precise folding and orientation of the zinc finger domains. Additionally, structure-activity relationship (SAR) studies are critical for optimizing the binding affinity and specificity of these inhibitors. Techniques such as high-throughput screening, computational modeling, and bioinformatics analyses are often employed to identify promising inhibitory molecules and refine their structures for maximum efficacy. The ability to selectively modulate ZFP810 activity opens up significant avenues for exploring the broader functions of zinc finger proteins in gene regulation, cellular differentiation, and homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor, potentially affecting gene expression including genes regulated by ZNF810. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, which could alter DNA methylation and potentially impact ZNF810 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that may affect protein degradation pathways, possibly stabilizing proteins that interact with or regulate ZNF810. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that could affect various signaling pathways, potentially altering ZNF810 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can influence cellular growth and proliferation, indirectly affecting the role of ZNF810. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor, which might impact cytoskeleton organization and potentially influence the cellular context of ZNF810. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor, potentially indirectly affecting transcription factors, including ZNF810, by altering signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An ERK inhibitor that could potentially affect pathways regulating transcription factors like ZNF810. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, potentially impacting stress response pathways and indirectly affecting ZNF810's activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, affecting signaling pathways and potentially ZNF810's function. | ||||||